Research Areas

The 2017 Access to Vaccines Index has mapped how vaccine companies are responding to global calls to improve immunisation coverage. The companies approach access to vaccines in differing ways, which are generally linked to their diverse pipelines, portfolios, revenues and sales.

The Index covers three Research Areas: Research & Development, Pricing & Registration; and Manufacturing & Supply. These are the three areas where vaccine companies have a critical role to play to improve access to vaccines.

The Access to Vaccines Index evaluates data from six companies in relation to vaccine pricing and registration in the following areas: Vaccine pricing decisions, Price trends, Transparency in pricing and Availability.

The Access to Vaccines Index examines six companies’ activities in relation to the manufacture and supply of vaccines in the following areas: Aligning supply and demand, Capacity building and Distribution and administration.